|
|
Volumn 358, Issue 9293, 2001, Pages 1563-
|
|
Patent protection versus public health
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CIPROFLOXACIN;
DOXYCYCLINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTHRAX;
CANADA;
DRUG COST;
EDITORIAL;
EPIDEMIC;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PATENT;
PRIORITY JOURNAL;
PUBLIC HEALTH;
UNITED STATES;
|
|
EID: 0035841662
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(01)06633-8 Document Type: Editorial |
|
Times cited : (17)
|
|
References (0)
|